2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Frederieke H. van der Baan, PhD

Professor
Netherlands Cancer Institute
Plesmanlaan 121
Amsterdam Netherlands 1066CX

Papers:
60 KRAS variant rs61764370 is not associated with ovarian cancer risk or survival in the Ovarian Cancer Association Consortium (OCAC) or Consortium of Modifiers of BRCA1 and BRCA2 (CIMBA)